iBio
IBIO
#10088
Rank
A$98.16 M
Marketcap
A$1.98
Share price
-1.06%
Change (1 day)
118.29%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): A-$1.17

According to iBio's latest financial reports the company's current EPS (TTM) is A-$1.06. In 2025 the company made an earnings per share (EPS) of A-$2.48 an increase over its 2024 EPS that were of A-$9.21.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.17-52.7%
2025A-$2.48-73.08%
2024A-$9.21-93.88%
2023A-$150.42-8.14%
2022A-$163.7592.67%
2021A-$84.99-80.33%
2020A-$432.03-35.11%
2019A-$665.75-38.96%
2018A-$1,091-6.1%
2017A-$1,16236.67%
2016A-$849.9033.33%
2015A-$637.4250%
2014A-$424.95-53.85%
2013A-$920.72-7.14%
2012A-$991.55-64.1%
2011A-$2,76277.27%
2010A-$1,558144.44%
2009A-$637.4212.93%
2008A-$564.4512.2%
2007A-$503.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.37-1,264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
A-$0.74-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$11.93 1,022.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$0.24-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA